Dwain Fehon, PsyD

Associate Professor of Psychiatry; Chief Psychologist, Psychiatric Services, Yale New Haven Hospital; Director, Behavioral Medicine Service

Research Departments & Organizations

Psychiatry: Psychological Medicine Service | Psychology Section

Yale Cancer Center

Office of Cooperative Research

Research Interests

Alcoholism; Anxiety; Behavioral Medicine; Depression; Diseases; Quality of Life; Resilience, Psychological; Stress Disorders, Post-Traumatic

Research Summary

My clinical, teaching, and research interests fall into several basic areas: a) the development and provision of behavioral medicine services, b) psychotherapy to adults with advanced medical illness, c) psychological and neuropsychological assessment, and d) the coordination of predoctoral internship training in clinical psychology within YNHH and YNHPH.

The research interests initially focused on the developmental period of adolescence and the impact that traumatic events, such as childhood abuse and the exposure to community violence played in the development and symptomatic expression of psychopathology—specifically as related to adolescent depression, aggression, substance abuse, PTSD, and personality dysfunction.

More recently, my clinical and research interests have shifted to behavioral medicine and the relationship between physical illness, emotional functioning, and quality of life. Clinically, my colleagues and I have developed a psychological behavioral medicine service that is integrated within the Yale Cancer Center/Smilow Cancer Hospital, Tobacco Treatment Service, Yale New Haven Hospital Transplantation Center, Yale Sleep Center and Yale Spine Center. Within these settings, we have initiated several pilot studies to examine the relationship between coping, resilience and quality of life, while also exploring the psychological, behavioral, and neuropsychiatric comorbidities among patients facing serious, chronic, and life threatening illnesses. We are also interested in developing novel therapies, and testing their feasibility and effectiveness for reducing the risk of adverse stress-related symptoms such as drug and alcohol abuse, depression, anxiety and PTSD in these vulnerable patient populations.

Specialized Terms: Behavioral Medicine; Resilience; Coping with chronic illness; Quality of life; Palliative Care; Depression; Psychotherapy

Extensive Research Description

Demoralization in cancer patients receiving palliative care. The specific aim of this research is to study the relationship between demoralization and certain other variables, such as spiritual well-being, sense of meaning, purpose in life, and overall quality of life in patients receiving palliative care. The long-term objective of this research is to contribute to the personalization of palliative care by designing an algorithm for evidence-based selection of psychotherapeutic interventions tailored to meet the needs of individual patients and aimed at countering demoralization, suicidal ideation or requests for hastened death. This study is currently undergoing IRB review and is slated to begin recruitment in March 2019. (Dr. John DeFigeuiredo, Primary Investigator; Dr. Dwain Fehon, Co-Investigator).

Psychiatric, psychological, and behavioral correlates in patients with end-stage liver disease awaiting organ transplantation. This exploratory study recruited and assessed 125 waitlisted liver transplant candidates using self-report measures of emotional adjustment and quality of life (Dr. Dwain Fehon, Primary Investigator).

Liver SMART: A Stress Management and Relaxation Training Intervention for Liver Transplant Candidates. This is a Stage 1A treatment development study examined the feasibility and preliminary effectiveness of an 8-session group cognitive-behavioral stress management intervention for liver transplant candidates (Dr. Dwain Fehon, Primary Investigator).

Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients. This study was an 8-week, randomized controlled pilot trial to investigate the feasibility and acceptability of a text-messaging intervention for alcohol relapse prevention and stress reduction in 20 liver transplant patients with alcohol-related liver disease (Dr. Benjamin Toll, Primary Investigator; Dr. Dwain Fehon, Co-investigator). 

Development of the Yale Liver Transplant Psychosocial Risk Scale (YLTRS). This study developed and performed an initial validation of a brief, evidence-based, clinician administered scale to assess level of psychosocial risk among liver transplant candidates (Dr. Dwain Fehon, Primary Investigator).

Clinical Trials

Conditions Study Title
Diseases of the Nervous System, Genetics - Adult, Genetics - Pediatric, Mental Health & Behavioral Research Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)

Selected Publications

Edit this profile